Members log in

Remember me

Do not refresh my screen on timeout

close

News

Valproate and childbearing potential: new regulations

Read More

Events

ABN/SBNS Joint meeting 19-21 September 2018 - abstract line now open

Read More

Domperidone

You will have recently received notification from the MRHA regarding a LOW RISK of serious cardiac side‐effect (prolonged QTc) with domperidone (see refs below). The ABN has asked the MHRA to provide guidance on the use of this drug in people with Parkinson’s disease, but they have not been able to do so.  Please click here for recommendations from the ABN. 

Back to contents

 

News

Valproate and childbearing potential: new regulations

Read More

Events

ABN/SBNS Joint meeting 19-21 September 2018 - abstract line now open

Read More